The Microsidd HIV 1 & 2 Rapid Test Kit – 50 Tests is a professional-use in-vitro diagnostic rapid test intended for the qualitative detection of antibodies to Human Immunodeficiency Virus Type 1 (HIV-1) and Type 2 (HIV-2) in compatible human specimens.
The test uses immunochromatographic lateral-flow technology to support rapid HIV antibody screening in professional healthcare and laboratory environments.
This 50-test pack is designed for trained healthcare professionals, diagnostic laboratories, pathology centres, hospitals, blood banks, institutional screening programmes and other appropriately supervised testing settings.
Important: This is a screening test. A reactive rapid-test result does not by itself establish a diagnosis of HIV infection. Reactive results must be managed and confirmed according to applicable national testing algorithms, laboratory protocols and professional guidance.
Brand: Microsidd
Product: HIV 1 & 2 Rapid Test Kit
Product Type: HIV Antibody Rapid Test
Category: Rapid Diagnostic Tests / Infectious Disease Testing
Detection: Antibodies to HIV-1 and HIV-2
Technology: Immunochromatographic Lateral Flow Assay
Result Type: Qualitative / Reactive or Non-Reactive Screening
Specimen: Whole Blood / Serum / Plasma, subject to current package insert
Format: Single-Use Rapid Test Device
Pack Size: 50 Tests
Intended Use: Professional In-Vitro Diagnostic Use Only
Seller / Brand Owner: Microsidd India
Location: RT Nagar, Bengaluru, Karnataka, India
The Microsidd HIV 1 & 2 Rapid Test is a rapid antibody screening test designed to detect antibodies associated with:
HIV Type 1
and
HIV Type 2
from compatible patient specimens.
The test is designed for situations where a rapid screening result is required as part of an appropriate professional HIV testing workflow.
The device is not intended to replace confirmatory laboratory testing or the complete HIV diagnostic algorithm.
The test is designed for qualitative screening for antibodies to both:
HIV-1
and
HIV-2
This makes it suitable for routine professional HIV antibody-screening workflows.
The test uses immunochromatographic lateral-flow technology, allowing results to be obtained without conventional analyzer-based ELISA equipment.
Each sales pack contains:
50 individual rapid tests
making the product suitable for clinics, laboratories, hospitals and institutional testing requirements.
The current Microsidd HIV rapid-test information lists:
Whole Blood
Serum
Plasma
as compatible specimen categories. Microsidd India
The exact permitted specimen type and volume must always be verified from the package insert supplied with the current batch.
This product is intended for use by appropriately trained personnel in professional healthcare environments.
| Specification | Details |
|---|---|
| Brand | Microsidd |
| Product | HIV 1 & 2 Rapid Test Kit |
| Pack Size | 50 Tests |
| Test Type | Rapid HIV Antibody Screening Test |
| Detection | HIV-1 & HIV-2 Antibodies |
| Technology | Immunochromatographic Lateral Flow |
| Result Type | Qualitative |
| Specimen | Whole Blood / Serum / Plasma* |
| Test Format | Single-Use Rapid Test Device |
| Use | Professional IVD |
| Interpretation | Reactive / Non-Reactive / Invalid according to IFU |
| Confirmatory Testing Required for Reactive Results | Yes |
*Subject to the current manufacturer/package insert supplied with the batch.
The test device contains immobilized reagents that interact with HIV antibodies present in the specimen.
After the specimen and specified assay buffer are applied according to the package insert, the sample migrates through the membrane by capillary action.
If the relevant antibodies are present above the assay detection threshold, a visible reaction line may appear in the appropriate test region.
A valid test must also show the required control line.
The exact appearance and interpretation of the control and test regions must be taken from the package insert supplied with the product.
A typical professional rapid-test workflow involves:
Do not use generic HIV test instructions for this product. Exact blood volume, buffer volume, timing and interpretation can differ between rapid-test kits. Your Microsidd Knowledge Hub correctly emphasizes this point. Microsidd India
A valid non-reactive result generally means that only the control indicator specified by the manufacturer is present and no reactive test indicator appears.
A non-reactive result does not always exclude very recent infection, particularly if testing occurs during the HIV antibody window period.
A reactive result indicates that HIV antibodies may be present.
A reactive rapid-test result must not be treated as a final diagnosis on its own.
Further testing should be performed according to the applicable national HIV testing algorithm and professional laboratory protocol.
If the required control indicator does not appear, the test is invalid.
The specimen should be retested using a new device according to the package insert.
This product is intended for screening, not standalone diagnosis.
| Rapid HIV Screening Test | Confirmatory HIV Testing |
|---|---|
| Provides preliminary antibody screening | Establishes infection status according to testing algorithm |
| Rapid lateral-flow format | May involve additional independent assays |
| Suitable for professional screening | Used after reactive screening where required |
| Qualitative result | Diagnostic algorithm dependent |
A reactive screening result must be interpreted within the appropriate testing algorithm rather than in isolation.
After HIV infection, antibodies may not become detectable immediately.
Therefore, a person tested very soon after a potential exposure may receive a non-reactive antibody test even though infection cannot yet be completely excluded.
Testing timing and the need for repeat testing should be determined by a qualified healthcare professional or according to current HIV testing guidelines.
The Microsidd HIV 1 & 2 Rapid Test 50-pack is intended for trained professionals working in environments such as:
This product is not intended as an unsupervised consumer home-use product.
The test may be used as part of appropriate professional workflows for:
Use must comply with applicable regulations, testing algorithms and healthcare protocols.
Both HIV-1 and HIV-2 are human immunodeficiency viruses.
HIV-1 is responsible for the majority of HIV infections worldwide, while HIV-2 is less common and has a different geographic distribution.
A professional screening test designed to detect antibodies to both HIV-1 and HIV-2 helps support broader antibody screening.
Store the test kit according to the temperature range printed on the product label and current package insert.
General precautions include:
Exact storage conditions printed on the supplied kit take precedence over website information.
During transportation:
Institutions should follow their standard procedures for transport and receipt of IVD reagents.
Users should follow the quality-control requirements stated in the current package insert and their laboratory SOPs.
Quality control may include:
Do not report patient results from an invalid test.
https://microsidd.com/blogs/knowledge-hub/hiv-rapid-test-kit-complete-guide
https://microsidd.com/blogs/knowledge-hub/how-to-use-hiv-rapid-test-kit
https://microsidd.com/collections/blood-bank-range
https://microsidd.com/collections/best-home-test-kits
HIV Rapid Test Complete Guide
https://microsidd.com/blogs/knowledge-hub/hiv-rapid-test-kit-complete-guide
How to Use an HIV Rapid Test Kit
https://microsidd.com/blogs/knowledge-hub/how-to-use-hiv-rapid-test-kit
Blood Bank Range
https://microsidd.com/collections/blood-bank-range
Rapid Diagnostic Tests
https://microsidd.com/collections/best-home-test-kits
Microsidd India supplies professional diagnostic products, rapid-test kits, blood-bank consumables and laboratory products through a specialist medical catalogue.
Benefits include:
✓ Microsidd-branded professional rapid-test range
✓ 50-test institutional pack
✓ Dedicated HIV educational content
✓ Related blood-bank and infectious-disease tests available
✓ Bengaluru-based customer support
✓ GST invoice where applicable
✓ Institutional supply support subject to availability
✓ Online ordering across serviceable locations in India
✓ Clear professional-use and result-interpretation guidance
Microsidd India supplies professional HIV rapid-test kits in Bengaluru and serves diagnostic laboratories, clinics, hospitals and healthcare institutions across serviceable locations in India.
Professional buyers searching for:
HIV rapid test kit Bangalore
HIV 1 and 2 test kit Bengaluru
HIV rapid test 50 tests India
professional HIV test kit Bangalore
HIV antibody rapid test Bengaluru
laboratory HIV rapid test near me
can order through Microsidd.com subject to stock and serviceability.
Business Name: Microsidd India
Address: #09, Green Chambers, 14th Cross, RT Nagar, Bengaluru – 560032, Karnataka, India
Phone / WhatsApp: +91 63667 72288
Email: support@microsidd.com
Website: https://microsidd.com
Working Hours: Monday to Saturday, 10:00 AM – 6:00 PM IST
For rapid-test guides, laboratory-product explainers and professional diagnostic content:
https://www.youtube.com/channel/UCun9gCID17Z5kK65W6JtIdg?sub_confirmation=1
For new diagnostic products, stock updates and offers:
https://whatsapp.com/channel/0029Va5lCoi1nozBZBL1gx3P
It is designed for qualitative screening for antibodies to HIV-1 and HIV-2.
This listing is for:
50 tests
No. Based on the intended product description, this is an HIV antibody rapid test.
Current Microsidd HIV rapid-test information lists:
Whole blood, serum and plasma, subject to the exact package insert supplied with the batch. Microsidd India
No.
This listing is intended for professional in-vitro diagnostic use only.
No.
A reactive rapid screening result requires further testing according to the applicable HIV testing algorithm.
Not always.
Testing during the antibody window period may produce a non-reactive result before detectable antibodies have developed.
Do not claim differentiation unless the actual supplied product insert specifically states separate HIV-1 and HIV-2 result lines.
For the generic Microsidd-branded listing, the safest wording is that the test detects antibodies to HIV-1 and HIV-2.
Use the exact reading time printed in the current package insert.
Do not assume that all HIV rapid tests use the same timing.
Use the exact specimen volume specified in the package insert supplied with the current batch.
Follow the current kit IFU exactly.
Buffer drop size and required volume can differ across rapid tests.
No.
Do not use the kit after its labelled expiry date.
No.
Each test device is intended for single use.
The test is invalid and should be repeated using a new device according to the IFU.
It may be used only where its intended use, regulatory status and local blood-bank procedures permit. Blood-bank screening should follow applicable statutory and institutional requirements.
https://microsidd.com/blogs/knowledge-hub/hiv-rapid-test-kit-complete-guide
This product is non-returnable and non-exchangeable.
Please verify the product name, test parameter, pack size, specimen type, intended use and product specifications before placing your order.
Professional customers should also verify that the test format and specimen requirements are suitable for their laboratory or institutional protocol.
Genuine cases involving an incorrect product received will be handled separately according to Microsidd.com's applicable policies and applicable law.
An original, continuous, unedited and uncut unboxing video is compulsory for making any claim regarding an incorrect product received.
The Microsidd HIV 1 & 2 Rapid Test Kit is intended for professional in-vitro diagnostic screening use only.
A reactive result must not be considered a definitive diagnosis of HIV infection on its own.
Reactive, discordant or clinically inconsistent results must be evaluated according to the applicable HIV testing algorithm, laboratory SOPs and current national guidance.
A non-reactive result may not exclude very recent infection because of the antibody window period.
Clinical decisions should be made by appropriately qualified healthcare professionals.
All specimens and used test materials should be treated as potentially infectious and handled and disposed of according to appropriate biosafety procedures.
| Specification name | Specification Value |
|---|---|
| Product certifications & standards | CDSCO, ISO |
| Test method | RDT, Lab analysis |
| Test sample | Blood |
